rs11568824

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The XR_007059988.1(ZSCAN25):​n.1429-1308C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.025 in 151,594 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.025 ( 78 hom., cov: 31)

Consequence

ZSCAN25
XR_007059988.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.113

Publications

6 publications found
Variant links:
Genes affected
ZSCAN25 (HGNC:21961): (zinc finger and SCAN domain containing 25) This gene encodes a protein that bears some similarity to zinc finger proteins, which are involved in DNA binding and protein-protein interactions. Multiple alternatively spliced transcript variants have been identified, but the full-length nature for most of them has not been determined. [provided by RefSeq, Jul 2008]
CYP3A7 (HGNC:2640): (cytochrome P450 family 3 subfamily A member 7) This gene encodes a member of the cytochrome P450 superfamily of enzymes, which participate in drug metabolism and the synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. This gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene and is represented by GeneID:100861540. [provided by RefSeq, Jan 2015]
CYP3A7-CYP3A51P (HGNC:51504): (CYP3A7-CYP3A51P readthrough) This locus represents readthrough transcription between the neighboring CYP3A7 (cytochrome P450, family 3, subfamily A, polypeptide 7) and CYP3A51P (cytochrome P450, family 3, subfamily A, polypeptide 51, pseudogene) genes, which are members of the CYP3A gene cluster on chromosome 7. The downstream pseudogene is not known to be independently transcribed. The readthrough transcript includes CYP3A7 exons 1-13 and exons 2 and 13 of the pseudogene. It encodes a CYP3A isoform with a novel C-terminus. This isoform is only expressed in alleles containing a T nucleotide at the -6 position of a splice acceptor in the pseudogene, which enables correct splicing of the upstream CYP3A7 exons to the pseudogene exons. It should be noted that the reference genome sequence represents the CYP3A7_39256 T->A allele, and thus this haplotype is unlikely to produce the readthrough transcript. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BS2
High Homozygotes in GnomAd4 at 78 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP3A7NM_000765.5 linkc.-291G>T upstream_gene_variant ENST00000336374.4 NP_000756.3 P24462-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP3A7ENST00000336374.4 linkc.-291G>T upstream_gene_variant 1 NM_000765.5 ENSP00000337450.2 P24462-1
CYP3A7ENST00000467776.1 linkn.-188G>T upstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0250
AC:
3784
AN:
151476
Hom.:
77
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00912
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0266
Gnomad ASJ
AF:
0.0280
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0133
Gnomad FIN
AF:
0.0470
Gnomad MID
AF:
0.0191
Gnomad NFE
AF:
0.0336
Gnomad OTH
AF:
0.0284
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0250
AC:
3785
AN:
151594
Hom.:
78
Cov.:
31
AF XY:
0.0249
AC XY:
1844
AN XY:
74072
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00912
AC:
378
AN:
41456
American (AMR)
AF:
0.0265
AC:
404
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
97
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.0135
AC:
65
AN:
4814
European-Finnish (FIN)
AF:
0.0470
AC:
495
AN:
10536
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.0336
AC:
2273
AN:
67618
Other (OTH)
AF:
0.0281
AC:
59
AN:
2100
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.361
Heterozygous variant carriers
0
183
367
550
734
917
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00261
Hom.:
15

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.0
DANN
Benign
0.40
PhyloP100
-0.11
PromoterAI
0.030
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11568824; hg19: chr7-99333007; API